---
title: "AstraZeneca held talks with Bristol-Myers through spring, summer - FT"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295571239.md"
description: "AstraZeneca and Bristol-Myers Squibb held serious talks for a stock-based acquisition through summer, nearing an agreement on price and financing. However, the deal collapsed after Financial Times reported on the potential tie-up in early August. Consequently, AstraZeneca's board terminated negotiations, causing its shares to plunge 9% on August 3."
datetime: "2026-08-11T19:32:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295571239.md)
  - [en](https://longbridge.com/en/news/295571239.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295571239.md)
generator: "portal-rs"
---

# AstraZeneca held talks with Bristol-Myers through spring, summer - FT

AstraZeneca (AZN) had discussions with Bristol-Myers Squibb (BMY) through the spring and summer about a potential deal. By early August, talks about a mostly stock-based deal where AstraZeneca (AZN) would purchase Bristol-Myers (BMY) for a premium were serious, according to a Financial Times report earlier on Tuesday, which cited people familiar wi...

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study](https://longbridge.com/en/news/297453992.md)
- [232,697 Shares in Bristol Myers Squibb Company $BMY Acquired by Beacon Pointe Advisors LLC](https://longbridge.com/en/news/297394340.md)
- [AstraZeneca Reports Positive Results Of SANOVO Phase III Trial In China](https://longbridge.com/en/news/297606938.md)
- [REG - AstraZeneca PLC - AstraZeneca completes agreement for Zegfrovy](https://longbridge.com/en/news/297603898.md)
- [Key facts: LSE:AZN Zegfrovy buy; SANOVO PFS; Wan Ling Martello named](https://longbridge.com/en/news/297611733.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**